NCT02432027View on ClinicalTrials.gov

Trial to Evaluate Topical C-82 in a Psoriasis Plaque Test

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

September 30, 2015

Conditions
Psoriasis
Interventions
DRUG

C-82 Topical Gel, Placebo

placebo

DRUG

C-82 Topical Gel, 1%

active

DRUG

Daivonex cream

comparator

DRUG

Diprosis gel

comparator

Trial Locations (1)

Unknown

Schwerin

All Listed Sponsors
lead

Prism Pharma Co., Ltd.

INDUSTRY

NCT02432027 - Trial to Evaluate Topical C-82 in a Psoriasis Plaque Test | Biotech Hunter | Biotech Hunter